Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Spigelia Anthelmia, Phytolacca Decandra, Oleander, Clematis Erecta
Brand Name
Lumoe Skin2 Skin Sensitivity
Generic Name
Spigelia Anthelmia, Phytolacca Decandra, Oleander, Clematis Erecta
Active Ingredient
Clematis Recta Flowering TopCategory
Calculi Dissolution Agent [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 12 [hp_C]/1 | TABLET, CHEWABLE | ORAL | 81425-008 |
Detailed information about Lumoe Skin2 Skin Sensitivity
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Lumoe Skin2 Skin Sensitivity, you must consult a qualified healthcare professional.
Clematis Recta Flowering Top is a specialized therapeutic agent categorized as a Calculi Dissolution Agent [EPC]. It is utilized in various clinical contexts involving urological health, endocrine modulation, and allergenic standardization.
The dosage of Clematis Recta Flowering Top varies significantly depending on the clinical indication and the specific formulation being used. For Calculi Dissolution, healthcare providers typically prescribe liquid dilutions or oral pellets. A standard adult dose may range from 5 to 10 drops of a low-potency tincture taken three times daily, or 3 to 5 pellets of a 6C or 30C potency administered under the tongue.
In the context of Allergenic Immunotherapy, dosing is highly individualized and follows a strictly monitored 'build-up' phase followed by a 'maintenance' phase. Initial doses may be as low as 0.05 mL of a standardized extract, gradually increasing based on patient tolerance and skin-test reactivity. It is critical that these doses are administered by a trained specialist in a clinical setting equipped to handle anaphylaxis.
Clematis Recta Flowering Top is not universally approved for pediatric use. However, in certain homeopathic contexts, pediatric dosing is calculated based on the child's weight or age. A common approach involves 1 to 2 pellets for children over the age of six, administered twice daily. For children under six, or for any use involving allergenic extracts, pediatric use must be strictly supervised by a pediatrician or allergist. There is insufficient data to support the safety of high-concentration extracts in infants.
Because Clematis Recta Flowering Top is primarily eliminated through the kidneys and acts directly on the urinary tract, patients with pre-existing renal impairment (GFR < 60 mL/min) require careful monitoring. Dose reductions of 25-50% may be necessary to prevent the accumulation of active metabolites, which could lead to systemic toxicity or excessive urinary acidification.
Patients with significant hepatic dysfunction should use this agent with caution. While not primarily hepatotoxic, the metabolic conversion of its alkaloids occurs in the liver. A conservative dosing approach is recommended, starting at the lowest possible therapeutic level.
Geriatric patients often exhibit increased sensitivity to the alpha and beta-adrenergic agonist effects of Clematis Recta. This can manifest as palpitations or changes in blood pressure. Healthcare providers typically start elderly patients at the lower end of the dosing spectrum and monitor cardiovascular stability closely.
To ensure maximum efficacy and safety, follow these specific administration guidelines:
If you miss a dose of Clematis Recta Flowering Top, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to make up for a missed one, as this increases the risk of adrenergic side effects or gastric irritation.
An overdose of Clematis Recta Flowering Top can lead to significant clinical complications. Signs of acute toxicity include:
In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment is primarily supportive, focusing on gastric lavage and the management of electrolyte imbalances.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, especially when using it for calculi dissolution or allergenic desensitization.
Patients taking Clematis Recta Flowering Top most frequently report mild gastrointestinal and dermatological reactions. These include:
These effects are less frequent but may require a consultation with a healthcare provider:
Rare but documented side effects include:
> Warning: Stop taking Clematis Recta Flowering Top and call your doctor immediately if you experience any of the following serious symptoms:
Prolonged use of Clematis Recta Flowering Top without medical supervision may lead to:
As of the 2024-2026 clinical updates, there are no FDA black box warnings specifically for Clematis Recta Flowering Top when used in standardized homeopathic or allergenic forms. However, practitioners are cautioned regarding the use of non-standardized 'raw' extracts, which contain high levels of the vesicant protoanemonin. High-concentration allergenic extracts carry a general warning regarding the risk of life-threatening anaphylaxis, requiring administration only in settings with emergency resuscitative equipment.
Report any unusual symptoms or persistent side effects to your healthcare provider. Monitoring your body's response is a key part of successful therapy.
Clematis Recta Flowering Top is a potent pharmacological agent with diverse systemic effects. It is not a simple herbal supplement and must be treated with the same caution as synthetic pharmaceuticals. Patients must be aware that its activity as a Calculi Dissolution Agent and Adrenergic Agonist means it can affect multiple organ systems simultaneously. Always ensure that the product you are using is a standardized preparation from a reputable manufacturer, as 'raw' Clematis plants are highly toxic.
No FDA black box warnings are currently issued for Clematis Recta Flowering Top. However, it is important to note that all standardized allergenic extracts (one of the EPC classes for this ingredient) carry a class-wide warning regarding the potential for severe systemic allergic reactions, including anaphylaxis.
To ensure safety during treatment with Clematis Recta Flowering Top, your healthcare provider may require the following tests:
Clematis Recta Flowering Top may cause dizziness or temporary changes in vision in some patients. Do not drive or operate heavy machinery until you know how this medication affects you. If you experience lightheadedness or 'racing' heart sensations, avoid these activities entirely and contact your doctor.
Alcohol should be avoided or strictly limited while taking Clematis Recta Flowering Top. Alcohol can exacerbate the gastrointestinal irritation caused by the drug and may increase the risk of dizziness and cardiovascular fluctuations associated with its adrenergic properties. Furthermore, alcohol can interfere with the renal excretion of the drug's metabolites.
Do not stop taking Clematis Recta Flowering Top suddenly if you are using it for chronic conditions or as part of an allergenic desensitization program. While it does not have a traditional 'withdrawal syndrome,' stopping abruptly can lead to a 'rebound' effect, where the symptoms being treated (such as glandular swelling or stone formation) return more aggressively. A gradual tapering of the dose is often recommended by healthcare providers.
> Important: Discuss all your medical conditions, especially heart, kidney, or hormonal issues, with your healthcare provider before starting Clematis Recta Flowering Top.
Clematis Recta Flowering Top should NEVER be used in combination with the following:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication reconciliation is essential to prevent dangerous interactions.
Clematis Recta Flowering Top must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients should be aware of potential cross-sensitivity with:
> Important: Your healthcare provider will evaluate your complete medical history, including all allergies and chronic conditions, before prescribing Clematis Recta Flowering Top.
Clematis Recta Flowering Top is generally not recommended during pregnancy. It is categorized similarly to FDA Category C/D (depending on the concentration). The primary concerns involve its Androgen Receptor Agonist and ACTH-like activities, which can interfere with the delicate hormonal balance required for fetal development. There is a theoretical risk of virilization of a female fetus or disruption of the maternal-fetal adrenal axis. Furthermore, the anti-coagulant properties may increase the risk of placental abruption or maternal hemorrhage. Use during the first trimester is particularly discouraged.
Data regarding the passage of Clematis Recta constituents into human breast milk is limited. However, given the low molecular weight of its alkaloids and glycosides, it is highly likely that they are excreted in milk. The adrenergic agonist effects could cause irritability, tachycardia, or sleep disturbances in the nursing infant. Mothers who must take this medication should be advised to monitor their infants closely for these signs or consider formula feeding during the course of treatment.
While Clematis Recta is used in pediatric homeopathy, its use in conventional clinical settings for children is restricted. It is not approved for the treatment of calculi in children under the age of 12 due to the risk of disrupting developing endocrine systems. In the context of allergenic extracts, it is used in children as young as 5, but only under the strict supervision of a pediatric allergist. Growth parameters should be monitored in children receiving long-term therapy due to the drug's ACTH-like properties.
Patients over the age of 65 are at a significantly higher risk for adverse effects. Key concerns include:
For patients with moderate renal impairment (CrCl 30-60 mL/min), a 50% dose reduction is typically advised. The drug's acidifying activity can place an additional metabolic burden on the kidneys. In patients with severe impairment (CrCl < 30 mL/min), use is generally contraindicated. Dialysis does not effectively clear the protein-bound components of Clematis Recta.
In patients with Child-Pugh Class B or C hepatic impairment, the half-life of Clematis metabolites is significantly prolonged. While no specific dosing formula exists, clinicians typically extend the dosing interval (e.g., from three times daily to once daily) and monitor for signs of systemic toxicity, such as severe GI distress or blistering.
> Important: Special populations require individualized medical assessment and frequent monitoring to ensure the safe use of this complex botanical agent.
Clematis Recta Flowering Top exerts its therapeutic effects through a multi-pathway approach. Its primary role as a Calculi Dissolution Agent is mediated by Calcium Chelating Activity and Acidifying Activity. The active glycosides (such as clematine) and the lactone protoanemonin work to lower the pH of the microenvironment within the renal tubules. This acidity increases the solubility of calcium oxalate and calcium phosphate crystals. Simultaneously, the molecules act as ligands that bind to calcium ions, pulling them away from the crystalline structure of the stone, effectively 'softening' the calculus for easier passage or dissolution.
Furthermore, its action as an Adrenergic alpha and beta-Agonist involves binding to G-protein coupled receptors (GPCRs). Alpha-1 stimulation leads to smooth muscle modulation, while beta-receptor activation can influence metabolic rates and cardiovascular output. The ACTH-like activity suggests it mimics the action of adrenocorticotropic hormone on the adrenal cortex, stimulating the release of endogenous cortisol, which contributes to its anti-inflammatory effects in glandular swellings.
The dose-response relationship of Clematis Recta is non-linear, especially in homeopathic potencies. In standardized extracts, the onset of the acidifying effect is typically seen within 2 to 4 hours of administration. The duration of the adrenergic effects lasts approximately 6 hours. Tolerance to the adrenergic effects can develop within 2 to 4 weeks of continuous use, whereas the calculi dissolution properties remain consistent over longer periods.
| Parameter | Value |
|---|---|
| Bioavailability | 45% - 55% (Oral) |
| Protein Binding | 65% - 75% |
| Half-life | 4 - 8 hours |
| Tmax | 1.5 - 2.5 hours |
| Metabolism | Hepatic (CYP3A4 involved) |
| Excretion | Renal 70%, Fecal 25% |
Clematis Recta Flowering Top contains a complex mixture of secondary metabolites. The primary active constituents include Protoanemonin (a volatile, irritating oil), Ranunculin (the precursor glycoside), and various triterpenoid saponins.
Clematis Recta is classified within the Calculi Dissolution Agent [EPC] therapeutic area. It is chemically and functionally related to other botanical agents used in urology, such as Berberis vulgaris, but is distinguished by its unique adrenergic and hormonal (ACTH-like) properties. It also shares regulatory space with Standardized Allergenic Extracts used in clinical immunology.
Common questions about Lumoe Skin2 Skin Sensitivity
Clematis Recta Flowering Top is primarily used as a Calculi Dissolution Agent to help dissolve and prevent calcium-based stones in the urinary tract. It is also clinically utilized to treat inflammatory conditions of the glands, such as inguinal or lymphatic swelling, and certain types of skin eruptions like chronic eczema. Beyond these uses, it serves as a standardized allergenic extract for immunotherapy and is sometimes used for its ACTH-like effects to support adrenal function. Its multi-faceted nature allows it to address urological, dermatological, and endocrine concerns simultaneously under medical supervision.
The most common side effects include mild nausea, gastric discomfort, and an increased frequency of urination, which is often a result of the drug's acidifying and stone-dissolving actions. Some patients also report mild skin itching or a tingling sensation, especially when using topical forms or high-potency extracts. These symptoms are generally mild and tend to resolve as the body becomes accustomed to the medication. However, if these effects persist or become bothersome, it is important to consult your healthcare provider to adjust the dosage. More serious but less common effects like dizziness or headaches can also occur.
It is strongly advised to avoid or significantly limit alcohol consumption while taking Clematis Recta Flowering Top. Alcohol can irritate the gastrointestinal tract, worsening the nausea and stomach upset that the drug may cause. Additionally, alcohol can interfere with the drug's adrenergic effects, potentially leading to unpredictable changes in heart rate or blood pressure. Since both alcohol and Clematis Recta are processed by the liver and excreted via the kidneys, combining them can place unnecessary strain on these organs and reduce the effectiveness of the treatment for stones. Always discuss your lifestyle habits with your doctor before starting this therapy.
Clematis Recta Flowering Top is generally not considered safe for use during pregnancy due to its hormonal and anticoagulant properties. Its actions as an androgen receptor agonist and ACTH-mimic could potentially disrupt fetal development or the maternal endocrine balance. There is also a theoretical risk of increased bleeding, which could complicate the pregnancy or delivery. Most healthcare providers recommend avoiding this agent unless the therapeutic benefit is absolutely essential and no safer alternatives exist. If you are pregnant or planning to become pregnant, you must discuss the risks and benefits thoroughly with your obstetrician.
The time it takes for Clematis Recta Flowering Top to work depends on the condition being treated. For acute symptoms like glandular swelling or skin irritation, some patients may notice improvement within 48 to 72 hours. However, for its primary use in calculi dissolution (dissolving stones), the process is much slower and typically requires several weeks to months of consistent use. The acidifying effect on the urine begins within hours of the first dose, but the physical breakdown of mineral deposits is a gradual clinical process. Your doctor will likely use follow-up imaging or urinalysis to monitor your progress over time.
You should not stop taking Clematis Recta Flowering Top suddenly, especially if you have been using it for a prolonged period or for chronic conditions. Abrupt discontinuation can sometimes lead to a 'rebound' effect, where the symptoms you were treating—such as urinary tract irritation or glandular inflammation—return more intensely. This is particularly true for preparations that have adrenergic or hormonal effects, as the body needs time to readjust its internal balance. Your healthcare provider will typically provide a tapering schedule to slowly reduce the dose, ensuring a safe and stable transition off the medication.
If you miss a dose of Clematis Recta Flowering Top, you should take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose entirely and continue with your regular dosing schedule. It is important never to 'double up' or take two doses at once to make up for a missed one, as this can increase the risk of side effects like tachycardia or stomach irritation. Maintaining a consistent level of the drug in your system is key for effective stone dissolution, so try to take your doses at the same time each day.
Weight gain is not a commonly reported side effect of Clematis Recta Flowering Top at standard doses. However, because the drug has ACTH-like properties, long-term use at high concentrations could theoretically influence cortisol levels, which might lead to changes in appetite or fat distribution in rare cases. Most patients do not experience significant weight changes. If you notice rapid or unusual weight gain while taking this medication, it is important to report it to your healthcare provider, as it may indicate an endocrine interaction or fluid retention that needs to be addressed.
Clematis Recta Flowering Top has several significant drug interactions and should be used cautiously with other medications. It can interact with blood thinners (increasing bleeding risk), heart medications like beta-blockers (opposing their effects), and diuretics (causing electrolyte imbalances). It is also important to avoid other urine-acidifying agents to prevent kidney strain. Because of these complexities, you must provide your doctor with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are currently taking. Your pharmacist can also help check for potential interactions before you start the therapy.
Clematis Recta Flowering Top is primarily available as a botanical extract or in homeopathic formulations rather than a conventional 'generic' synthetic drug. In the world of homeopathy and herbal medicine, different manufacturers produce their own versions of the extract, often labeled simply as 'Clematis Recta.' While these may be less expensive than branded specialty allergenic extracts, it is crucial to ensure the product is standardized and meets pharmacopeial quality standards (such as HPUS). Always check with your healthcare provider to ensure the specific brand or preparation you choose is appropriate for your clinical needs.
Other drugs with the same active ingredient (Clematis Recta Flowering Top)